Trading Signals: BCRX Stock Price Prediction and Forecast (Tue. Sep. 2, 2003 - Wed. Sep. 27, 2023)(BioCryst Pharmaceuticals, Inc.)
| BCRX latest price $7.0950 (1.28%) ($7.0950 - $7.0950) on Thu. Aug. 3, 2023. | |
| | Trend Analysis and Forecast | | | Average Daily Percentage Swing | 2.61% (three month average) | RSI | 52 | Latest Price | $7.0950(1.28%) | Stocks Behave Similarly | Similar Stock List | Daily Trend | BCRX declines -1.6% a day on average for past five trading days. | Weekly Trend | BCRX declines -0.3% a week on average for past two weeks. | Market Behavior | Value stocks sell-off for large cap. Normal for small cap. | Correlated ETFs | Broad market will support BCRX advance at 0% a week (0% probability) XBI(29%) GLD(20%) BND(19%) SLV(19%) VCIT(18%) | Factors Impacting BCRX price | BCRX will decline at least -1.305% in a week (0% probabilities). XLRE(-38%) XLP(-32%) SPLV(-24%) DIA(-24%) XLI(-21%) | | | | | Relative Volatility | | | | Market Trend Strength | -1.305% (StdDev 2.61%) | Hourly BBV | 0.2 () | Intraday Trend | 0% | | | |
|
Resistance Level | $7.32 | 5 Day Moving Average | $7.23(-1.87%) | 10 Day Moving Average | $7.41(-4.25%) | 20 Day Moving Average | $7.32(-3.07%) | To recent high | -19.9% | To recent low | 2.2% | Market Cap | $1.252b | | | | BioCryst Pharmaceuticals, Inc. designs and develops novel, oral and small-molecule medicines. Its drug candidates include Berotralstat, BCX9930, BCX9250, RAPIVAB, ALPIVAB, RAPIACTA, PERAMIFLU, Galidesivir and Mundesine. The company was founded in 1986 and is headquartered in Durham, NC. |